Showing results (351-360 of 437) with videos related to

Sort By:
Pageof 44
Environmental Science & Technology|February 10, 2021
Emissions Measurements from Household Solid Fuel Use in Haryana, India: Implications for Climate and Health Co-benefitsRobert M Weltman, Rufus D Edwards, Lauren T Fleming, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Opioid-driven disruption of the septal complex reveals a role for neurotensin-expressing neurons in withdrawalRhiana C Simon, Weston T Fleming, Pranav Senthilkumar, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 14, 2014
A new paradigm to understand and treat diabetic neuropathyA Hidmark, T Fleming, S Vittas, et al.
Neuron|May 16, 2025
Opioid-driven disruption of the septum reveals a role for neurotensin-expressing neurons in withdrawalRhiana C Simon, Weston T Fleming, Brandy A Briones, et al.
Breast Cancer Research and Treatment|September 13, 2014
Identification and translational validation of novel mammaglobin-A CD8 T cell epitopesS D Soysal, S Muenst, J Kan-Mitchell, et al.
BMC Cancer|December 19, 2014
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancerPrabhakar Rajan, Jacqueline Stockley, Ian M Sudbery, et al.
Physical Review Letters|April 7, 2010
Toward TeV conformalityT Appelquist, A Avakian, R Babich, et al.
Nature Protocols|September 3, 2011
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0Jan Schellenberger, Richard Que, Ronan M T Fleming, et al.
Biological Psychiatry Global Open Science|November 3, 2022
Perineuronal Nets in the Dorsomedial Striatum Contribute to Behavioral Dysfunction in Mouse Models of Excessive Repetitive BehaviorBrandy A Briones, Miah N Pitcher, Weston T Fleming, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancerG Sonpavde, V Matveev, J M Burke, et al.
Pageof 44